loading...| Preferred Name |
nabilone |
|
| Synonyms |
Cesamet |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C011941 |
|
| altLabel |
Cesamet Lilly 109514 nabilone, (trans-(+-))-isomer LY 109514 nabilone, (6aR-trans)-isomer nabilone, (cis-(+-))-isomer nabilone, (6aS-trans)-isomer 3-(1,1-dimethylheptyl)-6,6a,7,8,10,10a- hexahydro-1-hydroxy-6,6-dimethyl-9H-dibenzo(b,d)pyran-9-one |
|
| cui |
C0952388 C0952390 C0952389 C0969772 C0068333 C1263104 C0952387 |
|
| Has mapping qualifier | ||
| HM |
D013759/Q000031 |
|
| Inverse of RB |
56469-15-9 2N4O9L084N 61664-39-9 51022-71-0 0 61617-09-2 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to | ||
| MDA |
19760101 |
|
| MeSH Frequency |
198 |
|
| MMR |
20161223 |
|
| notation |
C011941 |
|
| PA |
D014151 D000932 |
|
| prefLabel |
nabilone |
|
| RR |
61664-39-9 ((6aS-trans)-isomer) 56496-90-3 56469-15-9 ((cis-(+-))-isomer) 51022-71-0 ((trans-(+-))-isomer) 61617-09-2 ((6aR-trans)-isomer) |
|
| SC |
1 |
|
| Scope Statement |
cannabinol deriv; RN given refers to cpd without isomeric designation; structure |
|
| SRC |
Clin Pharmacol Ther 22(1):85;1977 J Org Chem 42(13):2277;1977 JAMA 240(14):1469;1978 N Engl J Med 300(23):1295;1979 Res Commun Chem Pathol Pharmacol 23(1):61;1979 Therapeutic Potential Marihuana QV109 T 398:410;1975 Clin Pharmacol Ther 18(6):720;1975 Biomed Mass Spectrom 5(4):296;1978 Science 201(4357):694;1978 Psychopharm Bull 15(2):88;1978 Clin Pharmacol Ther 23(1):54;1978 N Engl J Med 298(26):1480;1978 J Pharm Pharmacol 29(12):783;1977 J Pharmacol Exp Ther 207(2):521;1978 Biomedicine 27:331;1977 |
|
| TERMUI |
T341660 T088597 T341658 T088598 T341659 T341661 T088599 T578242 |
|
| TH |
UK CA NLM (1976) USAN (19XX) INN (19XX) FDA SRS (2015) IE |
|
| tui |
T109 T121 |